What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Psychiatry
- Major depressive disorder
His primary scientific interests are in Bipolar disorder, Psychiatry, Clinical psychology, Neuroscience and Comorbidity.
His Bipolar disorder research is multidisciplinary, relying on both First episode, Prefrontal cortex and Neuroimaging.
His Psychometrics research extends to Psychiatry, which is thematically connected.
His work deals with themes such as Developmental psychology, Temperament and Reward dependence, which intersect with Clinical psychology.
His research integrates issues of Voxel, Psychosis, Voxel-based morphometry and Grey matter in his study of Neuroscience.
His studies in Mania integrate themes in fields like Quetiapine and Ziprasidone.
His most cited work include:
- Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. (988 citations)
- Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009 (476 citations)
- The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders (413 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Bipolar disorder, Psychiatry, Clinical psychology, Internal medicine and Bipolar II disorder.
He is studying Bipolar I disorder, which is a component of Bipolar disorder.
His work on Depression, Comorbidity and Schizophrenia as part of general Psychiatry research is frequently linked to In patient and Suicide prevention, bridging the gap between disciplines.
Within one scientific family, Kyooseob Ha focuses on topics pertaining to Rating scale under Clinical psychology, and may sometimes address concerns connected to Reliability.
Kyooseob Ha focuses mostly in the field of Internal medicine, narrowing it down to matters related to Endocrinology and, in some cases, MAPK/ERK pathway.
Bipolar II disorder is a subfield of Neuroscience that Kyooseob Ha studies.
He most often published in these fields:
- Bipolar disorder (61.08%)
- Psychiatry (43.35%)
- Clinical psychology (33.00%)
What were the highlights of his more recent work (between 2017-2021)?
- Bipolar disorder (61.08%)
- Internal medicine (40.89%)
- Major depressive disorder (21.67%)
In recent papers he was focusing on the following fields of study:
Kyooseob Ha mainly investigates Bipolar disorder, Internal medicine, Major depressive disorder, Clinical psychology and Oncology.
Psychiatry covers Kyooseob Ha research in Bipolar disorder.
In the subject of general Psychiatry, his work in Bipolar I disorder, Schizophrenia and Bipolar II disorder is often linked to In patient and Completed Suicide, thereby combining diverse domains of study.
Kyooseob Ha interconnects Endocrinology and Lipidomics in the investigation of issues within Internal medicine.
His Major depressive disorder study combines topics from a wide range of disciplines, such as Escitalopram, Disease and Drug.
His study in Clinical psychology is interdisciplinary in nature, drawing from both Longitudinal study, Permissive and Psychiatric history.
Between 2017 and 2021, his most popular works were:
- Exploration of comorbid obsessive-compulsive disorder in patients with bipolar disorder: The clinic-based prevalence rate, symptoms nature and clinical correlates. (16 citations)
- Genome-wide association study of over 40,000 bipolar disorder cases provides novel biological insights (9 citations)
- Serum lipidomic analysis for the discovery of biomarkers for major depressive disorder in drug-free patients (7 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Major depressive disorder
- Psychiatry
Bipolar disorder, Major depressive disorder, Disease, Internal medicine and Oncology are his primary areas of study.
Kyooseob Ha integrates many fields, such as Bipolar disorder and In patient, in his works.
Kyooseob Ha combines subjects such as Escitalopram, Blood plasma and Citalopram with his study of Major depressive disorder.
His Disease research incorporates elements of Proteome, Protein kinase A, Proteomics, Pathophysiology and Serum protein.
His work on Serum biomarkers as part of general Internal medicine research is often related to Biological materials, thus linking different fields of science.
His research combines Biomarker and Oncology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
